Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Versum opens books, begins to warm to rival suitor Merck KGaA

Published 03/29/2019, 02:04 PM
© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt

(Reuters) - Versum Materials Inc has opened its books to suitor Merck KGaA, saying the German group's unsolicited $5.9 billion offer might be sweetened and could edge out an agreed merger with Entegris.

"Merck’s proposal could reasonably be expected to result in a superior proposal," Versum, a maker of chemicals for the semiconductor industry, cited its board as saying in a statement on Friday.

However, the U.S. company again urged its shareholders to snub the hostile all-cash bid that Merck launched on Tuesday, adding its support for the tie-up with Entegris was unchanged for now.

The board "has authorized Versum's management and its advisers to engage in further discussions with, and provide non-public information to, Merck," the statement added.

Versum's share price, which dropped 27 percent last year, was up less than 1 percent on Friday afternoon, at $50.29, above the $48 a share offered by Merck.

Merck, a science company with three divisions that include specialty chemicals, welcomed Versum's move but maintained the pressure by keeping the June 7 deadline and all other terms of its tender offer unchanged, and by urging Versum investors not to back the Entegris deal.

Versum, the former specialty chemicals division of industrial gases group Air Products (NYSE:APD), has opposed Merck's bid since it was proposed last month, saying it was committed to the all-share merger with Entegris, agreed in January.

In a meeting between Versum Chairman Seifi Ghasemi and Merck Chief Executive Stefan Oschmann on Thursday - under a limited waiver granted by Entegris - Oschmann hinted at a sweetened bid, Versum said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Mr. Oschmann conveyed the possibility that Merck would improve the terms of the offer" after due diligence, Versum said in filings.

"As a disciplined buyer, we will begin a thorough due diligence process as soon as possible," a Merck spokesman said. "Once this process has been concluded, we will provide further information."

The German group's tender offer is the first major hostile bid by a German company for a U.S. target since BASF's 2006 approach for catalytic converter maker Engelhard, which ended up an agreed deal.

The moves by Merck and Entegris are viewed by some analysts as an effort to seize on beaten down stock prices in the volatile semiconductor industry after demand for mobile devices slowed and prices for memory chips sank.

Entegris is a producer of materials and systems for semiconductor fabrication.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.